Absci Corporation (ABSI)
NASDAQ: ABSI
· Real-Time Price · USD
2.87
-0.06 (-2.05%)
At close: Aug 18, 2025, 10:39 AM
-2.05% (1D)
| Bid | 2.87 |
| Market Cap | 429.13M |
| Revenue (ttm) | 4.82M |
| Net Income (ttm) | -107.48M |
| EPS (ttm) | -0.95 |
| PE Ratio (ttm) | -3.02 |
| Forward PE | -3.68 |
| Analyst | Buy |
| Ask | 2.88 |
| Volume | 1,008,921 |
| Avg. Volume (20D) | 5,104,509.9 |
| Open | 2.90 |
| Previous Close | 2.93 |
| Day's Range | 2.84 - 2.93 |
| 52-Week Range | 2.01 - 6.33 |
| Beta | 2.04 |
About ABSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Absci has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
Absci Corporation is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-17.66%
Absci shares are trading lower after the company a...
Unlock content with
Pro Subscription
3 months ago
-1.69%
ABSI stock has given up its prior gain. Absci shares were trading higher after the company announced it began dosing the first participants in its Phase 1 ABS-101 clinical trial.
